Jain, Rishi
Coss, Chris
Whooley, Peter
Phelps, Mitch
Owen, Dwight H.
Article History
First Online: 15 May 2020
Compliance with Ethical Standards
:
: Rishi Jain declares that he has no conflict of interest. Chris Coss has received compensation from Immuneering for service as a consultant; has patents pending on anti-cachexia therapeutic strategies; was a previous employee of GTx, Inc., which developed Enobosarm as an anti-cachexia therapy, but has had no financial or other relationship with GTx since 2014. Peter Whooley declares that he has no conflict of interest. Mitch Phelps declares that he has no conflict of interest. Dwight H. Owen has received research funding (paid to his institution) from Merck, Bristol-Myers Squibb, Palobiofarma, and Genentech; has received compensation from AstraZeneca for participation on an advisory board; and has received compensation from theMednet for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by any of the authors.